Abstract
Patients with both acute and chronic respiratory diseases often require drugs that are administered through aerosols. To obtain the expected results, inhalation therapy must be carried out correctly. Inhalation therapy must consider pharmacology, anatomy, cardiopulmonary physiology, as well as physical, chemical, and mathematical principles for appropriate delivery. The correct distribution of the drug to the airway also depends on the technique used and the selection of the most appropriate device for each patient, considering their age, diagnosis, and cognitive and motor skills. Particles are deposited in the airway mainly by inertial impaction, gravitational sedimentation, and diffusion. Deposition will depend on aerosol, equipment, and patient factors. Inhalation therapy must be recommended on the basis of the clinical situation and needs constant supervision.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Sources
Aguilar P, Mallol J. Flujos inspiratorios máximos en niños de 4–8 años. Implicancias para la inhalación de medicamentos en polvo. Arch Bronconeumol. 2000;36:3.
Amirav I, Newhouse M. Review of optimal characteristics of facemasks for valved holding chambers (VHCs). Pediatr Pulmonol. 2008;43:268–74.
Barrueto L, Aguirre V, Aguilar P. Aerosolterapia. In: Paris E, Sánchez I, Beltramino D, Copto A, editors. Meneghello Pediatría. 6ª ed. Madrid: Editorial Médica Panamericana; 2013. p. 1193.
Carvalho T, Peters J, Williams R. Influence of particle size on regional lung deposition. What evidence is there? Int J Pharm. 2011;406:1–10.
Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv. 2012;25:63–78.
Dolovich M, Ahrens R, Hess D, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. American College of Chest Physicians/American College of Asthma, Allergy and Immunology. Chest. 2005;127:335–40.
Geller D. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50:1313–21.
Iñiguez F. Terapia inhalatoria en los pacientes con ventilación mecánica domiciliaria. Neumología Pediátrica. 2008;3:87–99.
Laube B, Janssens H, de Jongh F, et al. What the pulmonary specialist should know about the new inhalation therapies. ERS/ISAM Task Force Report. Eur Respir J. 2011;37:1308–31.
Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy. 2013;2013:17; Article ID 102418.
Myers T. The science guiding selection of an aerosol delivery device. Respir Care. 2013;58:1963–73.
Newman S. Principles of metered-dose inhaler design. Respir Care. 2005;50:1177–90.
Rottier B, Rubin B. Asthma medication delivery: mist and myths. Pediatr Respir Rev. 2013;14:112–8.
Rubin B. Pediatric aerosol therapy: new devices and new drugs. Respir Care. 2011;56:1411–21.
Smutney C, Grant M, Kincey P. Device factors affecting pulmonary delivery of dry powders. Ther Deliv. 2013;4:939–49.
Wong J, Chan H, Kwok P. Electrostatics in pharmaceutical aerosols for inhalation. Ther Deliv. 2013;4:981–1002.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Iñiguez Osmer, F., Aguirre Camposano, V. (2020). Inhalation Therapy. In: Bertrand, P., Sánchez, I. (eds) Pediatric Respiratory Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-26961-6_61
Download citation
DOI: https://doi.org/10.1007/978-3-030-26961-6_61
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26960-9
Online ISBN: 978-3-030-26961-6
eBook Packages: MedicineMedicine (R0)